Novel treatment for life-threatening lung condition wins NSF support

(Purdue University) A Purdue University-affiliated startup developing a novel treatment for a life-threatening lung condition won a $256,000 Small Business Technology Transfer Phase I award from the National Science Foundation. Spirrow Therapeutics offers help for patients with acute respiratory distress syndrome, or ARDS, by restoring lung function with a nanopolymer surfactant that can be administered through the trachea as a fast-acting liquid or preemptive aerosol. The startup team also is looking to use the technology to help those infected with COVID-19.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news